First-line treatments in EGFR-mutated advanced non-small cell lung cancer: A network meta-analysis
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference48 articles.
1. NCCN Clinical Practice Guidelines in Oncology;National Comprehensive Cancer Network (NCCN);Non-small cell lung cancer,2018
2. 30 Immunotherapy in advanced NSCLC-from the 'tsunami' of therapeutic knowledge to a clinical practice algorithm: results from an international expert panel meeting of the Italian Association of Thoracic Oncology (AIOT);F De Marinis;ESMO Open,2018
3. Precision diagnosis and treatment for advanced nonsmall- cell lung cancer;M Reck;N Engl J Med,2017
4. North-East Japan Study Group. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR;M Maemondo;N Engl J Med,2010
5. Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin-paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002);North-East Japan Study Group;Ann Oncol,2013
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. EGFR-TKIs or EGFR-TKIs combination treatments for untreated advanced EGFR- mutated NSCLC: a network meta-analysis;2024-09-11
2. New insights into the biology and development of lung cancer in never smokers—implications for early detection and treatment;Journal of Translational Medicine;2023-08-31
3. Enhancing clinical potential of liquid biopsy through a multi-omic approach: A systematic review;Frontiers in Genetics;2023-04-03
4. Treatment strategies and outcomes for patients with EGFR-mutant non-small cell lung cancer resistant to EGFR tyrosine kinase inhibitors: Focus on novel therapies;Lung Cancer;2022-08
5. An updated network meta-analysis of EGFR-TKIs and combination therapy in the first-line treatment of advanced EGFR mutation positive non-small cell lung cancer;Frontiers in Oncology;2022-08-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3